Related Experiment Video
Updated: Jun 28, 2025

Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses
Published on: March 29, 2017
Inhibitory effect of food-functioned phytochemicals on dysregulated inflammatory pathways triggered by SARS-CoV-2: a
Ibrahim Jantan1,2, Nor Azrina Norahmad3, Yuandani2
1Institute of Systems Biology, Universiti Kebangsaan Malaysia, Bangi, Malaysia.
Abstract:
Inflammatory cascades of the dysregulated inflammatory pathways in COVID-19 can cause excessive production of pro-inflammatory cytokines and chemokines leading to cytokine storm syndrome (CSS). The molecular cascades involved in the pathways may be targeted for discovery of new anti-inflammatory agents. Many plant extracts have been used clinically in the management of COVID-19, however, their immunosuppressive activities were mainly investigated based on in silico activity. Dietary flavonoids of the extracts such as quercetin, luteolin, kaempferol, naringenin, isorhamnetin, baicalein, wogonin, and rutin were commonly identified as responsible for their inhibitory effects. The present review critically analyzes the anti-inflammatory effects and mechanisms of phytochemicals, including dietary compounds against cytokine storm (CS) and hyperinflammation via inhibition of the altered inflammatory pathways triggered by SARS-CoV-2, published since the emergence of COVID-19 in December 2019. Only a few phytochemicals, mainly dietary compounds such as nanocurcumin, melatonin, quercetin, 6-shagoal, kaempferol, resveratrol, andrographolide, and colchicine have been investigated either in in silico or preliminary clinical studies to evaluate their anti-inflammatory effects against COVID-19. Sufficient pre-clinical studies on safety and efficacy of anti-inflammatory effects of the phytochemicals must be performed prior to proper clinical studies to develop them into therapeutic adjuvants in the prevention and treatmemt of COVID-19 symptoms.
Insights
Dietary phytochemicals show potential anti-inflammatory effects against COVID-19 cytokine storm (CSS). Further pre-clinical research is needed to establish safety and efficacy before clinical use as therapeutic adjuvants.
Area of Science:
- Pharmacology
- Immunology
- Phytochemistry
Background:
- COVID-19 can trigger cytokine storm syndrome (CSS) due to dysregulated inflammatory pathways and excessive pro-inflammatory cytokines.
- Plant extracts and their phytochemicals are explored for managing COVID-19, with immunosuppressive activities often investigated via *in silico* methods.
- Dietary flavonoids like quercetin and kaempferol are frequently identified as key compounds in plant extracts exhibiting inhibitory effects.
Purpose of the Study:
- To critically analyze the anti-inflammatory effects and mechanisms of phytochemicals against COVID-19-induced cytokine storm and hyperinflammation.
- To review studies published since December 2019 focusing on phytochemical inhibition of SARS-CoV-2-triggered inflammatory pathways.
- To identify phytochemicals with preliminary evidence for anti-inflammatory effects against COVID-19.
Main Methods:
- Literature review of studies investigating phytochemicals and their anti-inflammatory mechanisms against COVID-19.
- Analysis of *in silico* and preliminary clinical data on selected phytochemicals.
- Focus on dietary compounds and their role in modulating inflammatory pathways.
Main Results:
- Several phytochemicals, including nanocurcumin, melatonin, quercetin, and resveratrol, have shown potential anti-inflammatory effects against COVID-19.
- These compounds primarily act by inhibiting altered inflammatory pathways triggered by SARS-CoV-2.
- Limited pre-clinical and clinical investigations exist for most identified phytochemicals.
Conclusions:
- Phytochemicals, particularly dietary compounds, warrant further investigation for their anti-inflammatory potential in managing COVID-19-related hyperinflammation.
- Rigorous pre-clinical studies on safety and efficacy are crucial before advancing these compounds to clinical trials as therapeutic adjuvants.
- Targeting molecular cascades in inflammatory pathways with phytochemicals offers a promising avenue for novel anti-inflammatory agent discovery.
More Related Videos
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
Related Concept Videos
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Hormonal Regulation
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
GPCRs Regulate Adenylyl Cylase Activity
Feedback Inhibition
Regulation of Food Intake